It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Trials of the experimental new H1N1 swine flu vaccine will start at eight university medical centres and clinics next month, starting with vaccines made by Sanofi Aventis and CSL Ltd., US health officials said on Wednesday.
The first round of tests will be in adults, but will quickly move to children, said Dr Karen Kotloff of the University of Maryland, who will be leading one of the trials.
Although some vaccine manufacturers have complained that the H1N1 vaccine is not especially easy to make, Kotloff said there would be enough. “I have been told that there is sufficient vaccine to perform the studies,” Kotloff said in a telephone interview.
The trials, likely to begin on August 10, should also have no trouble enrolling volunteers, she said. “There is a great deal of interest,” she said.
Trials of the experimental new H1N1 swine flu vaccine will start at eight university medical centres and clinics next month
How do we even know that the vaccines which will be tried on volunteers are the same as the ones which will be released en mass for the mandatory vaccinations?